UMC and WHO are vital players in a worldwide alliance to reduce the harm that medicines can cause.
Pharmacovigilance, striving for the safer use of medicines, is alive and active in many shapes and varieties in most parts of the world. Here, we give a glimpse of the large canvas before we focus on the major element of it at the heart of UMC’s work, the WHO Programme for International Drug Monitoring. These first pages offer a brief introduction to the science of pharmacovigilance across the world and the major players and activities it involves.
Learn more about the global story of the WHO and UMC